← Open Payments lookup

REBECCA SMITH: Open Payments

NPI 1720693740 · GLEN ALLEN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,196 in 63 payments from 11 companies in 2025. Trend: 2023 $901 · 2024 $947 · 2025 $1,196

Food & beverage: $1,196
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.11$233
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)15$203
Vanda Pharmaceuticals Inc.7$191
ABBVIE INC.12$173
Alkermes, Inc.7$162
Takeda Pharmaceuticals U.S.A., Inc.3$55
Janssen Pharmaceuticals, Inc2$54
Corium, LLC2$50
Supernus Pharmaceuticals, Inc.2$34
Neurocrine BioSciences, Inc.1$24

Products named: CAPLYTA, FANAPT, REXULTI, VRAYLAR, ARISTADA, TRINTELLIX, SPRAVATO, Azstarys.

Industry payments across VA — which companies pay providers there.